SecBot SecBot
144 ·Filed Nov 3, 2026

REGN

REGENERON PHARMACEUTICALS, INC.
NEUTRAL
Impact 2/10
Horizondays Processed13d 7h ago SEC0001969223-26-001124
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine director sale following an option exercise, with no unusual size or timing. The shares represent a tiny fraction of the company's market cap. Monitor for any Form 4 filing confirming the actual sale, but no material impact is expected.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$930.67
T+0 close · Nov 3, 2026 · via day close
Latest settled
+3.09%
T+5 · $959.41 · next T+20 in 16d
Vs SPY
+4.00%
α at T+5
Latest observation
+4.00%
T+7 · FF3 residual α
  1. T+0 · Nov 4 $930.67entry
  2. T+1 · 12d ago −2.98%α +1.43% · $902.90
  3. T+5 · 6d ago +3.09%α +4.00% · $959.41
  4. T+8 · todayOpen
  5. T+20 · in 16d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Huda Zoghbi filed a Form 144 notice of intent to sell 7,439 shares of Regeneron common stock, with an estimated aggregate market value of approximately $7.22 million based on the filing date. The shares were acquired through a stock option exercise on the same day, and the sale is planned for cash on the open market.

Key Facts

  • Filer: Huda Zoghbi, a director of Regeneron Pharmaceuticals
  • Shares to be sold: 7,439 shares of common stock
  • Estimated aggregate market value: $7,219,262.83
  • Shares acquired on 11/03/2026 via stock option exercise from the company
  • Broker: UBS Financial Services Inc
  • Sale intended for cash on the open market on or after 11/03/2026
  • Total shares outstanding per filing: 101,630,713
  • Proposed sale represents about 0.0073% of shares outstanding

Financial Impact

Approximately $7.2 million at filing date price, representing about 0.0073% of shares outstanding and an immaterial fraction of the $84.3B market cap

dilution

Risk Factors

  • Form 144 is an intent to sell; the sale may not be executed
  • Director sales, even routine, can be perceived negatively by some market participants

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
72% bullish (36 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001969223-26-001124
Document: 0001969223-26-001124-index.html0001969223-26-001124
Document: 0001969223-26-001124.txt0001969223-26-001124

Track record

53 reports on REGN

Performance horizon

11 of 17 bullish or bearish reports moved the stock their way by T+20. Best: +31.76% at T+20 after the Oct 6, 2026 report. 17 of 21 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry $951.23 Now $952.40 +0.12% settles Dec 16
  2. Nov 16, 2026today 144 Neutral 2/10 Entry $948.00 Now $952.40 +0.46% settles Dec 16
  3. Nov 12, 20264d ago Press Release Bullish 5/10 Entry $955.47 Now $952.40 −0.32% settles Dec 14
  4. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $904.35 Now $952.40 +5.31% settles Dec 7
  5. Nov 5, 202611d ago Insider Cluster Neutral 3/10 Entry $904.35 Now $952.40 +5.31% settles Dec 7
  6. Nov 4, 202612d ago 144 Neutral 1/10 Entry $902.90 Now $952.40 +5.48% settles Dec 4
  7. Nov 4, 202612d ago 144 Neutral 2/10 Entry $902.90 Now $952.40 +5.48% settles Dec 4
  8. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
  9. Nov 3, 202613d ago 144 Neutral 2/10 Viewing Entry $930.67 Now $952.40 +2.33% settles Dec 3
  10. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
Showing 10 of 53

US Market Status

Market Closed · Opens Wed (9h 43m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 3, 2026